Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: After-Hours Movers » 18:59
03/01/21
03/01
18:59
03/01/21
18:59
INO

Inovio

$11.64 /

+0.52 (+4.68%)

, ASLN

Aslan Pharmaceuticals

$5.22 /

+0.82 (+18.64%)

, TTEC

TTEC Holdings

$88.80 /

+4.49 (+5.33%)

, ZM

Zoom Video

$409.67 /

+35.805 (+9.58%)

, HLIO

Helios Technologies

$67.14 /

+1.295 (+1.97%)

, AMRC

Ameresco

$60.46 /

+3.18 (+5.55%)

, TMDX

TransMedics

$36.30 /

+0.33 (+0.92%)

, MREO

Mereo BioPharma

$3.96 /

+0.07 (+1.80%)

, ROKU

Roku

$420.23 /

+25.095 (+6.35%)

, NLSN

Nielsen

$23.15 /

+0.73 (+3.26%)

, FGEN

FibroGen

$50.35 /

+0.38 (+0.76%)

, AI

C3.ai

$120.78 /

+8.41 (+7.48%)

, INSG

Inseego

$15.00 /

+0.35 (+2.39%)

, LMND

Lemonade

$132.23 /

+6.5 (+5.17%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

, SCPL

SciPlay

$19.28 /

+1.07 (+5.88%)

, NIO

NIO

$49.79 /

+3.08 (+6.59%)

, SWCH

Switch

$17.69 /

+0.33 (+1.90%)

, NVAX

Novavax

$239.73 /

+8.52 (+3.68%)

, SRPT

Sarepta

$86.94 /

-0.07 (-0.08%)

, SILK

Silk Road Medical

$55.35 /

+0.53 (+0.97%)

, OSUR

OraSure

$11.08 /

+0.42 (+3.94%)

, APPF

AppFolio

$160.72 /

-4.985 (-3.01%)

, SGMS

Scientific Games

$50.79 /

+3.84 (+8.18%)

, MELI

MercadoLibre

$1,715.90 /

+80.81 (+4.94%)

, RDHL

RedHill Biopharma

$9.19 /

-0.33 (-3.47%)

, COHU

Cohu

$46.01 /

+2.46 (+5.65%)

, BYND

Beyond Meat

$147.09 /

+1.7 (+1.17%)

Check out this evening's…

ShowHide Related Items >><<
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
01/08/21 Benchmark
Inovio price target lowered to $15 from $25 at Benchmark
ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

03/01/21 Piper Sandler
Piper boosts Aslan target to $10 after positive atopic dematitis data
04/13/20 Piper Sandler
Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler
03/18/20 Piper Sandler
Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler
TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

12/17/20 Canaccord
TTEC Holdings price target raised to $90 from $77 at Canaccord
10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
01/13/21 Stifel
Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
01/13/21 Morgan Stanley
Investors have turned too negative on Zoom's persistence, says Morgan Stanley
12/24/20 DA Davidson
DA Davidson likes Zoom push into email, says buy on recent selloff
HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
05/29/20 Morgan Stanley
Morgan Stanley upgrades Helios to Equal Weight following underperformance
05/29/20 Morgan Stanley
Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/20 Truist
Helios Technologies price target lowered to $36 from $45 at SunTrust
AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

02/09/21 B. Riley Securities
Ameresco price target raised to $72 from $50 at B. Riley Securities
01/26/21 Craig-Hallum
Ameresco price target raised to $75 from $50 at Craig-Hallum
11/03/20 Craig-Hallum
Ameresco price target raised to $50 from $38 at Craig-Hallum
11/03/20 B. Riley Securities
Ameresco price target raised to $50 from $48 at B. Riley Securities
TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

02/24/21 Cowen
TransMedics price target raised to $44 from $20 at Cowen
10/08/20
Fly Intel: Top five analyst downgrades
10/08/20 JPMorgan
TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
10/08/20 JPMorgan
TransMedics downgraded to Neutral from Overweight at JPMorgan
MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

02/22/21 Needham
Roku price target raised to $550 from $400 at Needham
02/19/21 Truist
Roku price target raised to $480 from $390 at Truist
02/19/21 JPMorgan
Roku price target raised to $525 from $475 at JPMorgan
02/19/21 Oppenheimer
Roku price target raised to $500 from $260 at Oppenheimer
NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

03/01/21 Truist
Nielsen price target raised to $26 from $20 at Truist
01/28/21 Citi
Nielsen price target raised to $27 from $22 at Citi
11/03/20 Deutsche Bank
Nielsen price target lowered to $18 from $22 at Deutsche Bank
08/25/20 Truist
Nielsen price target lowered to $20 from $23 at Truist
FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

02/01/21 H.C. Wainwright
FibroGen initiated with a Buy at H.C. Wainwright
12/21/20 Mizuho
FibroGen should be bought on PDUFA extension weakness, says Mizuho
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
AI C3.ai
$120.78 /

+8.41 (+7.48%)

01/04/21 KeyBanc
C3.ai initiated with a Sector Weight at KeyBanc
01/04/21 Wedbush
Wedbush bullish on C3.ai, initiates with an Outperform
01/04/21 Canaccord
C3.ai initiated with a Hold at Canaccord
01/04/21 Morgan Stanley
C3.ai initiated with an Underweight at Morgan Stanley
INSG Inseego
$15.00 /

+0.35 (+2.39%)

02/17/21 Cowen
Inseego price target raised to $20 from $17 at Cowen
09/04/20 Stifel
Inseego 5G opportunity highlighted in meetings with management, says Stifel
08/06/20
Fly Intel: Top five analyst downgrades
08/06/20 Lake Street
Inseego price target raised to $17 from $13 at Lake Street
LMND Lemonade
$132.23 /

+6.5 (+5.17%)

01/21/21 Piper Sandler
Lemonade price target raised to $163 from $105 at Piper Sandler
11/23/20 Morgan Stanley
Root initiated with an Equal Weight at Morgan Stanley
11/12/20 Piper Sandler
Lemonade price target raised to $71 from $63 at Piper Sandler
11/02/20 Piper Sandler
Lemonade initiated with an Overweight at Piper Sandler
MORF Morphic
$84.57 /

+48.64 (+135.37%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
SWCH Switch
$17.69 /

+0.33 (+1.90%)

02/02/21
Truist sees Switch positioned for long-term growth, starts at Buy
02/02/21 Truist
Switch initiated with a Buy at Truist
01/13/21 Jefferies
Switch upgraded to Buy on earnings growth inflection at Jefferies
01/13/21 Jefferies
Switch upgraded to Buy from Hold at Jefferies
NVAX Novavax
$239.73 /

+8.52 (+3.68%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley Securities
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
02/18/21 B. Riley Securities
Novavax price target raised to $397 from $334 at B. Riley Securities
SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
11/11/20 Piper Sandler
Silk Road Medical price target raised to $58 from $54 at Piper Sandler
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

02/25/21 DA Davidson
AppFolio price target raised to $126 from $110 at DA Davidson
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
10/26/20 Keefe Bruyette
AppFolio initiated with a Market Perform at Keefe Bruyette
SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

02/09/21 Craig-Hallum
Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
01/19/21 Jefferies
Scientific Games price target raised to $55 from $50 at Jefferies
01/14/21 Truist
Scientific Games price target raised to $60 from $45 at Truist
01/14/21 Craig-Hallum
Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

03/01/21 Credit Suisse
MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse
02/11/21
Fly Intel: Top five analyst initiations
02/11/21 Scotiabank
Scotiabank starts MercadoLibre at neutral, awaits better entry point
02/11/21 Scotiabank
MercadoLibre initiated with a Sector Perform at Scotiabank
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

11/12/20 Roth Capital
RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
09/11/20 BTIG
RedHill Biopharma initiated with a Buy at BTIG
08/14/20 Roth Capital
Roth Capital maintains Buy on RedHill after 'noisy' quarter
07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
COHU Cohu
$46.01 /

+2.46 (+5.65%)

02/12/21 Craig-Hallum
Cohu price target raised to $73 from $45 at Craig-Hallum
02/12/21 B. Riley Securities
Cohu price target raised to $72 from $60 at B. Riley Securities
02/10/21 B. Riley Securities
B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
01/25/21 B. Riley Securities
Cohu price target raised to $60 from $46 at B. Riley Securities
BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

03/01/21 DA Davidson
Beyond Meat price target raised to $145 from $133 at DA Davidson
02/26/21 Piper Sandler
Beyond Meat relationship with McDonald's not much changed, says Piper Sandler
02/26/21 UBS
Beyond Meat price target raised to $130 from $107 at UBS
02/26/21 Goldman Sachs
Beyond Meat price target raised to $112 from $105 at Goldman Sachs
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

  • 03
    Mar
  • 03
    Mar
  • 03
    Mar
  • 02
    Mar
  • 10
    Feb
  • 21
    Jan
  • 13
    Jan
  • 14
    Jan
  • 14
    Dec
  • 09
    Dec
  • 31
    Aug
  • 02
    Jul
  • 11
    Jun
  • 03
    Jun
  • 27
    May
  • 06
    May
  • 17
    Mar
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:45
03/01/21
03/01
16:45
03/01/21
16:45
JNJ

Johnson & Johnson

$159.34 /

+0.92 (+0.58%)

, XOM

Exxon Mobil

$56.40 /

+2.02 (+3.71%)

, OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

, DKNG

DraftKings

$68.71 /

+7.24 (+11.78%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

The three major averages…

ShowHide Related Items >><<
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

03/01/21 JPMorgan
JPMorgan downgrades Athenex on 'huge surprise' from FDA
03/01/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/01/21 JPMorgan
Athenex downgraded to Neutral from Overweight at JPMorgan
03/01/21 Laidlaw
Athenex price target lowered to $13 from $38 at Laidlaw
DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

03/01/21 Craig-Hallum
DraftKings price target raised to $70 from $65 at Craig-Hallum
03/01/21 Canaccord
DraftKings price target raised to $80 from $65 at Canaccord
03/01/21 Northland
DraftKings price target raised to $70 from $55 at Northland
03/01/21 Benchmark
DraftKings price target raised to $69 from $66 at Benchmark
MORF Morphic
$84.57 /

+48.64 (+135.37%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

  • 07
    Oct
  • 10
    Sep
  • 19
    Jun
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

Earnings
Novavax reports Q4 EPS ($2.70), consensus ($1.49) » 16:11
03/01/21
03/01
16:11
03/01/21
16:11
NVAX

Novavax

$239.35 /

+8.14 (+3.52%)

Reports Q4 revenue…

Reports Q4 revenue $279.7M, consensus $304.88M. "Novavax continues to make significant strides towards bringing NVX-CoV2373, our COVID-19 vaccine candidate, to market," said Stanley C. Erck, President and Chief Executive Officer of Novavax. "With positive efficacy results, including against evolving variant strains, NVX-CoV2373 offers a highly unique profile, including the ability to ship and store the vaccine at traditional refrigerated temperatures. We believe these attributes support emergency use authorization and have initiated dialogue with regulators to pursue appropriate regulatory authorization. In addition, we have secured agreements for the delivery of approximately 300 million doses of NVX-CoV2373. In our efforts to provide fair and equitable access to our vaccine around the world, we are proud to partner with the Serum Institute of India to jointly supply 1.1 billion doses of NVX-CoV2373 to Gavi through the COVAX Facility. We continue to work tirelessly to make final commercial preparations in advance of delivering our product across the globe."

ShowHide Related Items >><<
NVAX Novavax
$239.35 /

+8.14 (+3.52%)

NVAX Novavax
$239.35 /

+8.14 (+3.52%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley Securities
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
02/18/21 B. Riley Securities
Novavax price target raised to $397 from $334 at B. Riley Securities
NVAX Novavax
$239.35 /

+8.14 (+3.52%)

NVAX Novavax
$239.35 /

+8.14 (+3.52%)

NVAX Novavax
$239.35 /

+8.14 (+3.52%)

NVAX Novavax
$239.35 /

+8.14 (+3.52%)

Hot Stocks
FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA » 16:06
03/01/21
03/01
16:06
03/01/21
16:06
FGEN

FibroGen

$50.19 /

+0.22 (+0.44%)

, AZN

AstraZeneca

$48.21 /

-0.14 (-0.29%)

FibroGen (FGEN) and its…

FibroGen (FGEN) and its partner, AstraZeneca (AZN), announced that the Cardiovascular and Renal Drugs Advisory Committee of the FDA will hold an advisory committee, or AdCom, meeting to review the new drug application for roxadustat in the U.S. The companies have not received a confirmed AdCom meeting date from the FDA. "While disappointed with the news today, FibroGen and AstraZeneca are committed to working with the FDA to bring roxadustat to patients with anemia of CKD in the U.S. as soon as possible," said Enrique Conterno, CEO, FibroGen. "We continue to be confident in the efficacy and safety profile of this potential new medicine based on positive results from a global Phase 3 program encompassing more than 8,000 patients."

ShowHide Related Items >><<
FGEN FibroGen
$50.19 /

+0.22 (+0.44%)

AZN AstraZeneca
$48.21 /

-0.14 (-0.29%)

FGEN FibroGen
$50.19 /

+0.22 (+0.44%)

02/01/21 H.C. Wainwright
FibroGen initiated with a Buy at H.C. Wainwright
12/21/20 Mizuho
FibroGen should be bought on PDUFA extension weakness, says Mizuho
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
AZN AstraZeneca
$48.21 /

-0.14 (-0.29%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 UBS
AstraZeneca upgraded to Buy from Neutral at UBS
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
FGEN FibroGen
$50.19 /

+0.22 (+0.44%)

AZN AstraZeneca
$48.21 /

-0.14 (-0.29%)

AZN AstraZeneca
$48.21 /

-0.14 (-0.29%)

FGEN FibroGen
$50.19 /

+0.22 (+0.44%)

AZN AstraZeneca
$48.21 /

-0.14 (-0.29%)

FGEN FibroGen
$50.19 /

+0.22 (+0.44%)

AZN AstraZeneca
$48.21 /

-0.14 (-0.29%)

Conference/Events
Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 15:48
03/01/21
03/01
15:48
03/01/21
15:48
ADVM

Adverum Biotechnologies

$13.31 /

+0.455 (+3.54%)

, UBX

Unity Biotechnology

$7.53 /

+0.7 (+10.25%)

, AGTC

Applied Genetic

$5.64 /

+0.54 (+10.59%)

, JNJ

Johnson & Johnson

$159.50 /

+1.08 (+0.68%)

, MGTX

MeiraGTx

$15.21 /

+0.4 (+2.70%)

, NITE

Nightstar Therapeutics

$25.41 /

+ (+0.00%)

, BIIB

Biogen

$272.79 /

-0.16 (-0.06%)

, AERI

Aerie Pharmaceuticals

$19.36 /

+0.96 (+5.22%)

, ALDX

Aldeyra

$12.20 /

-0.05 (-0.41%)

Biopharmaceuticals…

Biopharmaceuticals Analyst Chen, along with Dr. Ruchita Amin, Retina Specialist at Retina Vitreous Associates and Dr. Roger Goldberg, Partner and Vitreoretinal Surgeon at Bay Area Retina Associates, discuss hot topics and key 2021 focus areas in eye diseases on an Analyst/Industry Conference Call to be held on March 8 at 1 pm.

ShowHide Related Items >><<
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

02/16/21 Citi
Unity Biotechnology downgraded to Sell from Neutral at Citi
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Morgan Stanley
Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint
08/18/20 Citi
Unity Biotechnology downgraded to Neutral from Buy at Citi
AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
11/11/20 H.C. Wainwright
Applied Genetic XLRP data 'continue to impress,' says H.C. Wainwright
JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

02/16/21 Chardan
MeiraGTx called a Top Pick for 2021 at Chardan
12/17/20 Chardan
Chardan boosts MeiraGTx target to $55, say buy shares 'now'
12/17/20 Piper Sandler
Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works'
10/22/20 RBC Capital
MeiraGTx initiated with an Outperform at RBC Capital
NITE Nightstar Therapeutics
$25.41 /

+ (+0.00%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

02/08/21 H.C. Wainwright
Aldeyra initiated with a Buy at H.C. Wainwright
01/28/21 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

  • 28
    Jan
  • 14
    Jan
  • 19
    Nov
  • 13
    Aug
JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

Options
Novavax options imply 15.7% move in share price post-earnings » 15:34
03/01/21
03/01
15:34
03/01/21
15:34
NVAX

Novavax

$237.35 /

+6.14 (+2.66%)

Pre-earnings options…

Pre-earnings options volume in Novavax is normal with calls leading puts 19:7. Implied volatility suggests the market is anticipating a move near 15.7%, or $37.46, after results are released. Median move over the past eight quarters is 10.9%.

ShowHide Related Items >><<
NVAX Novavax
$237.35 /

+6.14 (+2.66%)

NVAX Novavax
$237.35 /

+6.14 (+2.66%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley Securities
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
02/18/21 B. Riley Securities
Novavax price target raised to $397 from $334 at B. Riley Securities
NVAX Novavax
$237.35 /

+6.14 (+2.66%)

NVAX Novavax
$237.35 /

+6.14 (+2.66%)

NVAX Novavax
$237.35 /

+6.14 (+2.66%)

NVAX Novavax
$237.35 /

+6.14 (+2.66%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:23
03/01/21
03/01
12:23
03/01/21
12:23
JNJ

Johnson & Johnson

$160.50 /

+2.08 (+1.31%)

, XOM

Exxon Mobil

$57.12 /

+2.74 (+5.04%)

, OTRK

Ontrak

$30.17 /

-28.96 (-48.98%)

, ATNX

Athenex

$5.78 /

-6.41 (-52.61%)

, GRPN

Groupon

$59.42 /

+16.18 (+37.42%)

, MORF

Morphic Holding

$74.48 /

+38.55 (+107.29%)

The major averages are…

ShowHide Related Items >><<
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

MORF Morphic Holding
$74.48 /

+38.55 (+107.29%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

ATNX Athenex
$5.78 /

-6.41 (-52.61%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
ATNX Athenex
$5.78 /

-6.41 (-52.61%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Evercore ISI
Athenex initiated with an Outperform at Evercore ISI
10/26/20
Fly Intel: Top five analyst initiations
10/26/20 SVB Leerink
Athenex initiated with an Outperform at SVB Leerink
GRPN Groupon
$59.42 /

+16.18 (+37.42%)

03/01/21 JPMorgan
JPMorgan upgrades Groupon to Neutral on new marketplace strategy
03/01/21 JPMorgan
Groupon upgraded to Neutral from Underweight at JPMorgan
01/04/21 Barclays
Groupon assumed with an Underweight at Barclays
11/02/20 Wedbush
Groupon price target lowered to $21 from $27 at Wedbush
MORF Morphic Holding
$74.48 /

+38.55 (+107.29%)

02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

MORF Morphic Holding
$74.48 /

+38.55 (+107.29%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

ATNX Athenex
$5.78 /

-6.41 (-52.61%)

  • 10
    Sep
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

ATNX Athenex
$5.78 /

-6.41 (-52.61%)

XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

Options
Moderna call volume above normal and directionally bullish » 11:45
03/01/21
03/01
11:45
03/01/21
11:45
MRNA

Moderna

$147.15 /

-7.75 (-5.00%)

Bullish option flow…

Bullish option flow detected in Moderna with 22,687 calls trading, 1.0x expected, and implied vol increasing over 1 point to 75.16%. Jul-21 170 calls and 3/12 weekly 220 calls are the most active options, with total volume in those strikes near 5,500 contracts. The Put/Call Ratio is 0.48. Earnings are expected on May 5th.

ShowHide Related Items >><<
MRNA Moderna
$147.15 /

-7.75 (-5.00%)

MRNA Moderna
$147.15 /

-7.75 (-5.00%)

03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
02/26/21 Brookline
Moderna price target raised to $205 from $180 at Brookline
02/25/21 Piper Sandler
Moderna transitioning into profitable company, says Piper Sandler
MRNA Moderna
$147.15 /

-7.75 (-5.00%)

  • 19
    May
MRNA Moderna
$147.15 /

-7.75 (-5.00%)

MRNA Moderna
$147.15 /

-7.75 (-5.00%)

MRNA Moderna
$147.15 /

-7.75 (-5.00%)

Options
Unusually active option classes on open March 1st » 09:40
03/01/21
03/01
09:40
03/01/21
09:40
RCL

Royal Caribbean

$93.43 /

+ (+0.00%)

, NRG

NRG Energy

$36.50 /

+ (+0.00%)

, JNJ

Johnson & Johnson

$158.52 /

+0.1 (+0.06%)

, PBR

Petrobras

$7.92 /

+ (+0.00%)

, XOM

Exxon Mobil

$54.38 /

+ (+0.00%)

, RKT

Rocket Companies

$21.84 /

+ (+0.00%)

, C

Citi

$65.86 /

+ (+0.00%)

, BA

Boeing

$212.02 /

+ (+0.00%)

, WMT

Walmart

$129.87 /

-0.02 (-0.02%)

, PENN

Penn National

$115.83 /

+0.02 (+0.02%)

Unusual total active…

Unusual total active option classes on open include: Royal Caribbean (RCL), NRG Energy (NRG), Johnson & Johnson (JNJ), Petrobras (PBR), Exxon Mobil (XOM), Rocket Companies (RKT), Citi (C), Boeing (BA), Wal-Mart (WMT), and Penn National (PENN).

ShowHide Related Items >><<
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

PBR Petrobras
$7.92 /

+ (+0.00%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

02/24/21 Credit Suisse
Royal Caribbean price target raised to $117 from $76 at Credit Suisse
02/23/21 JPMorgan
Royal Caribbean price target raised to $100 from $91 at JPMorgan
02/23/21 Deutsche Bank
Royal Caribbean price target raised to $79 from $62 at Deutsche Bank
02/12/21 Berenberg
Royal Caribbean downgraded to Sell from Hold at Berenberg
NRG NRG Energy
$36.50 /

+ (+0.00%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Citi
NRG Energy resumed with a Buy at Citi
01/28/21 Goldman Sachs
NRG Energy reinstated with a Buy at Goldman Sachs
01/11/21 BofA
BofA US 1 List changes
JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
PBR Petrobras
$7.92 /

+ (+0.00%)

02/22/21
Fly Intel: Top five analyst downgrades
02/22/21 Scotiabank
Scotiabank downgrades Petrobras on rising fuel price tension
02/22/21 BofA
Petrobras double-downgraded to Underperform from Buy at BofA
02/22/21 BofA
Petrobras downgraded to Underperform from Buy at BofA
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
RKT Rocket Companies
$21.84 /

+ (+0.00%)

01/19/21 JPMorgan
JPMorgan double downgrades Rocket on more cautious mortgage stance
01/19/21 JPMorgan
Rocket Companies downgraded to Underweight from Overweight at JPMorgan
12/17/20 Keefe Bruyette
Rocket Companies downgraded to Underperform at Keefe Bruyette
12/14/20
Fly Intel: Top five analyst initiations
C Citi
$65.86 /

+ (+0.00%)

03/01/21 Wells Fargo
Citi price target raised to $82 from $74 at Wells Fargo
01/21/21 Berenberg
Berenberg downgrades Citi to Hold after 50% rally
01/21/21 Berenberg
Citi downgraded to Hold from Buy at Berenberg
01/19/21 DA Davidson
Citi price target raised to $84 from $77 at DA Davidson
BA Boeing
$212.02 /

+ (+0.00%)

03/01/21 Morgan Stanley
Boeing price target raised to $250 from $230 at Morgan Stanley
02/19/21 Benchmark
Boeing price target lowered to $270 from $290 at Benchmark
02/10/21 Deutsche Bank
Airbus initiated with a Buy at Deutsche Bank
01/29/21
Fly Intel: Top five analyst upgrades Spire
WMT Walmart
$129.87 /

-0.02 (-0.02%)

02/23/21 Evercore ISI
Walmart accelerating change with investments, says Evercore ISI
02/19/21 Morgan Stanley
Walmart terminal value rising with investments, says Morgan Stanley
02/19/21 Cowen
Walmart weakness a buying opportunity, says Cowen
02/19/21 Deutsche Bank
Walmart price target lowered to $166 from $170 at Deutsche Bank
PENN Penn National
$115.83 /

+0.02 (+0.02%)

02/23/21 JPMorgan
JPMorgan ups Penn National target, says don't wait for selloff to buy
02/22/21 Craig-Hallum
Craig-Hallum reiterates $150 target on Penn National after Rush deal
02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
02/05/21 Truist
Penn National price target raised to $135 from $120 at Truist
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

  • 01
    Mar
  • 14
    Oct
  • 25
    Sep
  • 06
    Aug
  • 12
    May
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

PBR Petrobras
$7.92 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

PBR Petrobras
$7.92 /

+ (+0.00%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

On The Fly
Fly Intel: Pre-market Movers » 09:15
03/01/21
03/01
09:15
03/01/21
09:15
JNJ

Johnson & Johnson

$158.52 /

-4.28 (-2.63%)

, XOM

Exxon Mobil

$54.38 /

-1.37 (-2.46%)

, XRAY

Dentsply Sirona

$53.11 /

+0.64 (+1.22%)

, PRGO

Perrigo

$40.20 /

-0.58 (-1.42%)

, NRG

NRG Energy

$36.50 /

-1.06 (-2.82%)

, SSYS

Stratasys

$34.48 /

+0.29 (+0.85%)

, LOGI

Logitech

$108.00 /

+2.23 (+2.11%)

, ATNX

Athenex

$12.18 /

+0.29 (+2.44%)

, CEO

Cnooc

$118.84 /

-8.41 (-6.61%)

, VACQ

Vector Acquisition

$10.27 /

-0.01 (-0.10%)

Check out this morning's…

ShowHide Related Items >><<
XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

CEO Cnooc
$118.84 /

-8.41 (-6.61%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

02/09/21 Stifel
Dentsply Sirona checks point to potential channel conflict, says Stifel
01/08/21 Credit Suisse
Envista upgraded to Outperform from Neutral at Credit Suisse
01/05/21 Baird
Dentsply Sirona price target raised to $62 from $58 at Baird
01/05/21 Barclays
Dentsply Sirona price target raised to $44 from $40 at Barclays
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
10/19/20 Morgan Stanley
Morgan Stanley sees volatility in Perrigo on Irish tax litigation ruling
06/16/20 JPMorgan
Perrigo tax dispute well reflected in shares, says JPMorgan
NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Citi
NRG Energy resumed with a Buy at Citi
01/28/21 Goldman Sachs
NRG Energy reinstated with a Buy at Goldman Sachs
01/11/21 BofA
BofA US 1 List changes
SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

01/19/21 Stifel
Stratasys initiated with a Buy at Stifel
01/15/21 JPMorgan
Stratasys downgraded to Underweight from Neutral at JPMorgan
10/09/20 Berenberg
Stratasys initiated with a Buy at Berenberg
09/24/20
Fly Intel: Top five analyst downgrades
LOGI Logitech
$108.00 /

+2.23 (+2.11%)

02/22/21 UBS
Logitech price target raised to CHF 108 from CHF 90 at UBS
02/10/21 DA Davidson
Corsair Gaming price target raised to $52 from $33 at DA Davidson
01/21/21 UBS
Logitech price target raised to CHF 90 from CHF 74 at UBS
01/20/21 Citi
Logitech price target raised to $130 from $110 at Citi
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Evercore ISI
Athenex initiated with an Outperform at Evercore ISI
10/26/20
Fly Intel: Top five analyst initiations
10/26/20 SVB Leerink
Athenex initiated with an Outperform at SVB Leerink
CEO Cnooc
$118.84 /

-8.41 (-6.61%)

01/04/21 Bernstein
Cnooc upgraded to Outperform from Market Perform at Bernstein
12/01/20 Bernstein
Cnooc downgraded to Market Perform from Outperform at Bernstein
11/22/20 Goldman Sachs
Cnooc initiated with a Buy at Goldman Sachs
08/19/20 Credit Suisse
Cnooc upgraded to Outperform from Underperform at Credit Suisse
VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

  • 10
    Sep
XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.